Cargando…
Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study
As vaccine-induced immunity and protection following natural pertussis infection wane over time, adults and adolescents may develop pertussis and become transmitters to unprotected infants. In Russia, diphtheria and tetanus but not pertussis-containing vaccines are registered for older children, ado...
Autores principales: | Asatryan, Asmik, Meyer, Nadia, Scherbakov, Michael, Romanenko, Victor, Osipova, Irina, Galustyan, Anna, Shamsheva, Olga, Latysheva, Tatiana, Myasnikova, Tatyana, Baudson, Nathalie, Dodet, Monique, Xavier, Stebin, Harrington, Lauriane, Kuznetsova, Anastasia, Campora, Laura, Van den Steen, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993191/ https://www.ncbi.nlm.nih.gov/pubmed/32845735 http://dx.doi.org/10.1080/21645515.2020.1796423 |
Ejemplares similares
-
Estimating the Effectiveness of Tetanus-Diphtheria-Acellular Pertussis Vaccine
por: Decker, Michael D., et al.
Publicado: (2015) -
Tetanus–diphtheria–acellular pertussis vaccination for adults: an update
por: Lee, Hyo-Jin, et al.
Publicado: (2017) -
Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and
Acellular Pertussis Vaccination
por: Hansen, John, et al.
Publicado: (2021) -
Investigating Tetanus, Diphtheria, Acellular Pertussis Vaccination During Pregnancy and Risk of Congenital Anomalies
por: Florea, Ana, et al.
Publicado: (2022) -
Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study
por: Romanenko, Victor, et al.
Publicado: (2020)